Multiple Myeloma Autologous Stem Cell Transplant

The widespread use of high dose therapy and autologous stem cell transplantation asct as well as the introduction of novel agents have significantly improved outcomes in multiple myeloma mm enabling long term survival.

Multiple myeloma autologous stem cell transplant.

A stem cell transplant replaces unhealthy blood cells with healthy ones. A stem cell transplant in combination with high dose chemotherapy is a treatment option that offers a chance for durable remission for people with multiple myeloma. Autologous stem cell transplant or infusion. It can be a strong weapon in your fight against multiple myeloma.

Then the patient receives new healthy blood forming stem cells. In a stem cell transplant the patient gets high dose chemotherapy to kill the cells in the bone marrow. Since high dose treatment destroys the normal bone marrow in addition to the myeloma cells the collected stem cells are unfrozen and given back into the bloodstream through an intravenous into a vein catheter one to two days after administration of the high dose chemotherapy. Autologous stem cell transplant multiple myeloma time factors abstract as multiple myeloma mm treatments evolve frequent updates are required to monitor the long term effect of changes in approach.

Autologous and allogeneic stem cell transplants. Because the chemotherapy attacks all the blood cells in the bone marrow not just the multiple myeloma cells a stem cell transplant provides the body with a new source of. We here analyze factors influencing survival in 865 newly diagnosed mm patien.